Prenetics Global Limited

NASDAQ:PRE

Medical - Diagnostics & Research

Healthcare
$10.35 +2.19%

+$0.43 today

Market cap
$185.61M
Beta
0.24
P/E (TTM)
-4.9
EPS (TTM)
-$4.18
52W Low $7.18High $23.63

Volume 1.58M

Average 0.22M

PRE Other Non-current Assets

Long-term assets not reported separately.

Prenetics Global LimitedNASDAQ: PRE

Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026

Other non-current assets rises 3159.5% from a year ago

Other non-current assets stood at $40.22M at the end of Q1 FY2026, up 3159.5% from a year earlier and up 502.3% from the prior quarter. Over 3 fiscal years it compounded at -4.2% a year.

Context

  • Other non-current assets amounted to 22.9% of total assets at the end of Q1 FY2026, up 22.3 pp from a year earlier.
  • Other non-current assets increased in 1 of the last 3 fiscal years.

What to watch

Whether other non-current assets keeps rising in the next quarterly balance sheet after a +3159.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$40.22M+502.3% QoQ
Last fiscal yearDec 2025
$6.68M+393.9% YoY
Year agoMar 2025
$1.23M+3159.5% since
Other Non-current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3159.5%——
1 year+393.9%——
3-year CAGR-4.2%——
5-year CAGR——
10-year CAGR——

Other Non-current Assets history

USD · from the balance sheet

Latest · FY2025
6.68M USD
Year-over-year change
+393.9%
4-year CAGR
+76.2%

Other Non-current Assets vs competitors

How PRE compares with its peers on the latest reported figures

  • PRE's Mar 2026 other non-current assets of $40.22M is the highest of the 11 companies compared; the peer median is $1.05M.
  • Its year-over-year change of +3159.5% is the highest of 10, against a peer median of -10.6%.
  • Other non-current assets amounts to 22.9% of total assets for PRE, versus a peer median of 1.3%.
PRE Competitors Peer median
Other Non-current Assets for PRE and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PREPrenetics Global LimitedMar 2026$40.22M +3159.5%-4.2%22.9%
STIMNeuronetics, Inc.Mar 2026$9.81M -9.4%-4.9%7.8%
SGMOSangamo Therapeutics, Inc.Mar 2026$9.63M -32.3%-7.1%16.1%
MXCTMaxCyte, Inc.Mar 2026$2.61M +36.4%+45.0%1.3%
ATLNAtlantic International Corp.Dec 2025$2.26M +135.0%+166.7%2.0%
OSUROraSure Technologies, Inc.Mar 2026$1.28M -12.2%+6.2%0.3%
ARMPArmata Pharmaceuticals, Inc.Mar 2026$813K -16.6%-26.3%1.2%
CDXSCodexis, Inc.Mar 2026$594K -70.7%+10.1%0.5%
IMDXInsight Molecular Diagnostics Inc.Mar 2026$574K -10.6%+50.3%1.4%
TLSITriSalus Life Sciences, Inc.Mar 2026$69K -6.8%-46.4%0.1%
PROFProfound Medical Corp.Mar 2026$0 ——0.0%
Peer median (excluding PRE) $1.05M-10.6%+6.2%1.3%

Competitors are the stored peer set for PRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents35.29M146.66M45.71M52.25M32.13M
Short-term Investments9.91M37.46M27.03M10.56M29.36M
Net Receivables47.05M42.5M5.29M5.61M2.98M
Inventory6.83M4.53M3.13M6.57M7.06M
Other Current Assets7.31M4.58M8.31M3.55M11.86M
Total Current Assets106.89M241.81M93.66M86.15M83.39M
Property, Plant & Equipment (Net)13.04M13.1M5.78M7.81M1.76M
Goodwill3.98M33.8M29.17M37.36M0
Intangible Assets23.83M14.79M13.43M11.57M44.7M
Long-term Investments0788.47K107.84M69.33M67M
Tax Assets79.7K243.45K28K00
Other Non-current Assets693.55K7.6M4.27M1.35M6.68M
Total Non-current Assets41.61M70.32M160.51M127.43M120.13M
Total Assets148.51M312.13M254.17M213.58M203.52M
Account Payables9.98M7.29M1.67M3.67M7.73M
Short-term Debt1.67M0001.33M
Tax Payables1.22M8.65M7.44M78K0
Deferred Revenue9.59M5.67M6.11M6.49M3.09M
Other Current Liabilities22.64M17.47M15.49M15.07M15.5M
Total Current Liabilities58.74M57.2M39.48M36.55M27.67M
Long-term Debt486.4M000437K
Deferred Tax Liabilities659.5K3.19M2.62M2.17M8K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities04.52M1.05M499K460K
Total Non-current Liabilities490.66M11.47M4.53M5.68M1.34M
Total Liabilities549.4M68.67M44.01M42.23M29.01M
Common Stock1.49K13.7K18K19K25K
Retained Earnings0(408.04M)(470.77M)(517.07M)0
Accumulated OCI(400.81M)(185.69M)(176.03M)(169.25M)0
Other Stockholders Equity(24K)000174.58M
Minority Interest(84.98K)6.4M3.8M957K(93K)
Total Equity(400.89M)243.46M210.16M171.35M174.51M
Total Debt491.67M6.65M2.37M5.77M2.2M
Net Debt456.38M(140.01M)(43.34M)(46.48M)(29.93M)

Prenetics Global Limited

NASDAQ:PRE

Intrinsic Alpha fair value

Locked

Current Price

$10.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.